Adolescent & Young Adult (AYA) Oncology Program

Adolescent & Young Adult (AYA) Oncology Program

  • About
  • Approach
  • Services
  • Appointments
  • Research
  • Locations
  • Doctors

    • If you are a cancer patient aged 15-39, we understand your unique needs and challenges. Balancing high school, college, career, or family life while managing a cancer diagnosis can be isolating. Our Adolescent and Young Adult Oncology Program is here to support you.

    Our Approach

    Our Adolescent & Young Adult Oncology Program is a multidisciplinary team that treats cancer patients aged 15-39. The team is made up of adult and pediatric oncologists; adolescent medicine and adult and pediatric social workers; researchers and others with expertise in supporting adolescents and young adults living with cancer. Our program initiatives are led by our AYA Patient Advisory Council, which is composed of young people who have gone through cancer treatment.

    Services

    Appointment Information

    Referrals are recommended through your care team. To contact the AYA Oncology Program team, please call 734-936-7518. 

    Support is funded through WHO Cares: Teen Cancer America and generous donors.

    Research

    Led by our director of research, Anao Zhang, PhD, we partner with the School of Social Work to facilitate patient centered research aimed to improve the lives of young people during and after cancer treatment. Learn more about the research arm of the Adolescent & Young Adult Oncology on the AYA CARE website. 

    Little boy showing excitement with raised arms over his head. He is wearing a block out cancer t-shirt.

    Block Out Cancer

    Learn how you can be part of our efforts to #BlockOutCancer.

    Donate online now

    Locations
    • Pediatric Hematology Oncology Clinic | Trinity Health Oakland Hospital 44555 Woodward Avenue, Suite 505
      Pontiac, MI 48341       Get Directions
    • Pediatric Oncology | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception C
      Ann Arbor, MI 48109-4257       Get Directions

    Doctors

     Search for a U-M Health doctor     Rashmi Chugh, MD

    Rashmi Chugh, MD

    Clinical Professor

    Medical Oncology, Hematology, Internal Medicine

    Michigan Photo

    Emily Byrnes Walling, MD, MPHS

    Clinical Associate Professor

    Pediatric Hematology-Oncology, Pediatrics

    Lauren May-Bond Wozniak, MD

    Lauren May-Bond Wozniak, MD

    Clinical Assistant Professor

    Adolescent Medicine, Pediatrics

    News & Stories

         couple with 3 dogs on porch smiling
    Health Lab

    Receiving personalized treatment for a rare neuroendocrine tumor

    Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.
         couple sitting on bench black and white kissing on cheek
    Health Lab

    Helping an employee-turned-patient overcome a brain tumor

    A patient with a brain tumor talks about their experience being an employee receiving care at Michigan Medicine.
         clear see through pill floating with other little pills behind in blue teal pink background
    Health Lab

    Stopping Ewing sarcoma relapses where they start

    Research on stopping Ewing sarcoma relapses through Michigan Medicine.
         yellow black purple red cell in middle mostly black
    Health Lab

    Study sheds light on how early pancreas lesions become cancerous

    Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
         hockey player with doctor on right holding pink and purple jersey
    Health Lab

    Teenage patient receives treatment for papillary thyroid cancer

    Teen hockey player Gavin Hewitt was diagnosed with papillary thyroid cancer and underwent surgery and radioactive iodine treatment.
         woman touching her neck in robe at home
    Health Lab

    Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers

    University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.